SKI Market

A+| A| A-|

Indian Indices

Sensex

77,664.00 -852.49
( -1.09%)

Global Indices

Nasdaq

49,509.71 339.32
(0.69%)

Dow Jones

7,158.76 73.75
(1.04%)

Hang Seng

59,249.10 -336.76
(-0.57%)

Nikkei 225

10,468.22 -8.24
(-0.08%)

Forex

USD-INR

93.44 0.45
(0.48%)

EUR-INR

109.88 0.43
(0.39%)

GBP-INR

126.24 0.55
(0.44%)

JPY-INR

0.59 0.00
(0.27%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

36.79

34689.63

EPS(TTM)

Face Value()

Div & Yield %

75.48

1.01

Back

ajanta pharma ltd

Ajanta Pharma consolidated net profit rises 17.56% in the December 2025 quarter

Jan 30,2026

Net profit of Ajanta Pharma rose 17.56% to Rs 273.77 crore in the quarter ended December 2025 as against Rs 232.88 crore during the previous quarter ended December 2024. Sales rose 19.95% to Rs 1374.84 crore in the quarter ended December 2025 as against Rs 1146.13 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1374.84	1146.13	20
OPM %	27.80	27.99	-
PBDT	402.11	343.36	17
PBT	358.60	307.39	17
NP	273.77	232.88	18

77,664.00 -852.49 ( -1.09%)

49,509.71 339.32 (0.69%)

7,158.76 73.75 (1.04%)

59,249.10 -336.76 (-0.57%)

10,468.22 -8.24 (-0.08%)

93.44 0.45 (0.48%)

109.88 0.43 (0.39%)

126.24 0.55 (0.44%)

0.59 0.00 (0.27%)